ICD Code C50.911

ICD code C50.911 is a classification used to identify a malignant neoplasm, or cancer, located in an unspecified site of the right female breast. This code is part of the International Classification of Diseases (ICD) system, which is used by healthcare providers to accurately document and communicate diagnoses. The "unspecified site" indicates that the exact location within the right breast where the cancer is present has not been detailed in the medical record. This code is crucial for billing, treatment planning, and statistical analysis in healthcare settings.

1. Presence of a Malignant Tumor: The patient must have a confirmed diagnosis of a malignant neoplasm, indicating the presence of cancerous cells.

2. Location Specificity: The tumor must be located in the right breast. However, the specific site within the breast is not determined or specified.

3. Gender Specification: The patient should be identified as female, as this code is specific to the female breast.

4. Unspecified Site: While the tumor is confirmed to be in the right breast, the exact location within the breast (such as upper quadrant, lower quadrant, etc.) is not specified or known.

5. Clinical Evaluation: The diagnosis should be based on clinical evaluation, which may include imaging studies, biopsy results, and other diagnostic tests that confirm the presence of a malignant neoplasm.

6. Exclusion of Other Conditions: Other potential causes for the symptoms or findings should be ruled out to confirm that the condition is indeed a malignant neoplasm of the right breast.

7. Documentation: Proper documentation in the patient's medical records should reflect the diagnosis of a malignant neoplasm of the right breast with an unspecified site to ensure accurate coding and billing.

For the ICD code C50.911, which pertains to a malignant neoplasm of an unspecified site of the right female breast, the relevant CPT codes that may be applicable for treatment and management include:

1. 19120 - Excision of cyst, fibroadenoma, or other benign or malignant tumor, aberrant breast tissue, duct lesion, nipple or areolar lesion; open, one or more lesions.

2. 19301 - Mastectomy, partial (e.g., lumpectomy, tylectomy, quadrantectomy, segmentectomy).

3. 19303 - Mastectomy, simple, complete.

4. 38500 - Biopsy or excision of lymph node(s); open, superficial.

5. 38792 - Injection procedure; for identification of sentinel node.

6. 77067 - Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed.

7. 77063 - Screening digital breast tomosynthesis, bilateral (list separately in addition to code for primary procedure).

8. 96402 - Chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic.

9. 96413 - Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug.

10. 77385 - Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; simple.

These CPT codes are examples of procedures and treatments that may be utilized in the management of a malignant neoplasm of the breast, depending on the specific clinical scenario and treatment plan. It is important for healthcare providers to select the appropriate CPT codes based on the services rendered and the individual patient's treatment needs.

Discover how MD Clarity's RevFind software can enhance your revenue cycle management by accurately reading your contracts and detecting underpayments for CPT codes related to ICD code C50.911. Ensure you're receiving the full reimbursement you deserve. Schedule a demo today to see RevFind in action and protect your practice's financial health.